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Abstract: BACKGROUND: Blood transfusion is used to treat acute anemia with the goal of increasing
blood oxygen-carrying capacity as determined by hematocrit (Hct) and oxygen delivery (DO2). However,
increasing Hct also increases blood viscosity, which may thus lower DO2 if the arterial circulation is
a rigid hydraulic system as the resistance to blood flow will increase. The net effect of transfusion
on DO2 in this system can be analyzed by using the relationship between Hct and systemic blood
viscosity of circulating blood at the posttransfusion Hct to calculate DO2 and comparing this value
with pretransfusion DO2. We hypothesized that increasing Hct would increase DO2 and tested our
hypothesis by mathematically modeling DO2 in the circulation. METHODS: Calculations were made
assuming a normal cardiac output (5 L/min) with degrees of anemia ranging from 5% to 80% Hct
deficit. We analyzed the effects of transfusing 0.5 or more units of 300 cc of packed red blood cells
(PRBCs) at an Hct of 65% and calculated microcirculatory DO2 after accounting for increased blood
viscosity and assuming no change in blood pressure. Our model accounts for O2 diffusion out of the
circulation before blood arriving to the nutritional circulation and for changes in blood flow velocity. The
immediate posttransfusion DO2 was also compared with DO2 after the transient increase in volume due
to transfusion has subsided. RESULTS: Blood transfusion of up to 3 units of PRBCs increased DO2
when Hct (or hemoglobin) was 60% lower than normal, but did not increase DO2 when administered
before this threshold. CONCLUSIONS: After accounting for the effect of increasing blood viscosity on
blood flow owing to increasing Hct, we found in a mathematical simulation of DO2 that transfusion of
up to 3 units of PRBCs does not increase DO2, unless anemia is the result of an Hct deficit greater
than 60%. Observations that transfusions occasionally result in clinical improvement suggest that other
mechanisms possibly related to increased blood viscosity may compensate for the absence of increase in
DO2.
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Anemia, defined as a hemoglobin (Hb) concentration below normal, results in a decreased blood oxygen (O2)-carrying capacity (CaO2) because of a lower Hb 
concentration. Blood transfusion is often used to treat acute 
anemia with the goal of increasing blood CaO2 and oxygen 
delivery (DO2). However, blood transfusion also introduces 
hydraulic changes that may limit its physiological effects. 
Blood transfusion is assumed to increase DO2 by increasing 
Hb and thus DO2. However, this increase is mitigated in a cir-
culatory system where the blood pressure (mean arterial pres-
sure [MAP]) and the arterial blood vessel diameter component 
of peripheral vascular resistance (total peripheral resistance 
[TPR]) remain constant, ie, a “rigid linear hydraulic system”1 
because the increase of hematocrit (Hct) increases blood vis-
cosity (µ), which then decreases blood flow and reduces DO2.
Other factors also complicate a simple relationship 
between Hct and DO2. Blood transfusion increases blood 
volume, but this volume expansion seldom leads to hyper-
volemia, because clinically most transfusions are given 
to hypovolemic patients. Transfusion thus transiently 
improves the filling of the heart (increased end-diastolic vol-
ume; preload) and thus cardiac output (CO). However, ane-
mia itself increases CO.2 By correcting anemia, packed red 
blood cell (PRBC) transfusion reverses this compensatory 
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mechanism. The net result is that PRBC transfusion in many 
studies increases DO2 only slightly, and in many instances, 
O2 consumption stays the same.2,3
A consequence of the relationship between Hct and 
blood viscosity is that increasing the Hct in anemia may 
not correspondingly increase DO2. This apparently para-
doxic finding is because increasing Hct will increase blood 
viscosity, which in turn will impede blood flow and reduce 
DO2. To test this possibility, we developed a mathematical 
model to determine how changes in Hct caused by a blood 
transfusion might affect CaO2 and blood viscosity and con-
sequently DO2 in an anemic organism.
METHODS
Model Design
We assumed a model circulatory system where under nor-
mal conditions 5 L of blood at a Hct = 45% (Hb = 14.5 g/dL) 
is circulated at the rate of 5 L/minute, where blood exits 
the heart at a pressure P that remains constant for all condi-
tions and that blood is 100% O2 saturated also for all con-
ditions. Anemia is modeled as a percent decrease in Hct, 
whereas all other circulatory parameters remain constant, 
except for blood viscosity. DO2 is calculated as the product 
of CO times Hct. The O2 saturation of blood arriving to the 
nutritional microcirculation is corrected for diffusional O2 
loss owing to the transit of blood through the circulation, 
which is assumed to be blood flow velocity-dependent. 
Furthermore, we assume that blood is a Newtonian fluid, 
which is mostly valid for Hct deficits of 40% or greater.4
Blood transfusion to correct Hb level is typically admin-
istered as PRBCs delivering up to 2 to 3 units of blood using 
leuko-reduced blood centrifuged to an Hct of 60% to 70%. 
To model this process, we defined a unit of blood as 300 
mL of PRBCs at 65% Hct. We then modeled how transfu-
sion accomplished the objective of increasing DO2 by using 
PRBC transfusion.
To make our scenario clinically relevant, we simulated 
0.5- to 3-unit transfusions. Hospitals reporting statistics 
on the number of units used per transfusion intervention5 
support this assertion. In Western Australia, 14% and 44% 
of the total blood supply is used in 1- and 2-unit transfu-
sions,6 whereas the percentage of units used per event in 18 
Austrian hospitals was 13% for 1-unit and 56% for 2-unit 
transfusions.7
In this analysis, we calculate the effect of transfusing 0.5 
units (150 cc), 1 unit (300 cc), 2 units (600 cc), and 3 units 
(900 cc) of PRBCs.
The Effect of Anemia on Blood Viscosity (µ)
Blood viscosity (µ) is a nonlinear function of Hct and shear 
rate, which varies throughout the circulation. In our model, 
we assumed a shear rate ~200 1/sec to be representative 
for the circulation. Arterial and venous Hcts (~3% higher 
than arterial) are the highest in the circulation and in ter-
minal arterioles and capillaries Hct is approximately half 
the central value.7 Although Hct varies among the arterial, 
microvascular, and venous compartments, we assumed that 
the arterial Hct and any changes resulting from the addi-
tion of PRBCs was effective Hct in determining blood vis-
cosity. This assumption was supported in part because the 
arterial circulation accounts for 70% of TPR. The microcircu-
lation where Hct is lower accounts for ~20% of TPR and the 
venous system contributes the remaining 10%.8
Our model assumes that the circulation is a rigid lin-
ear hydraulic system that accommodates blood volume 
changes in the venous circulation. However, because the 
venous systems accounts for only 10% of the total TPR, we 
assume that venous diameter changes are negligible and 
therefore TPR depends only on blood viscosity, which is a 
function of Hct.
The effect of Hct on µ was modeled by curve-fitting a 
quadratic equation to the data in the literature. This rela-
tionship was in part determined by the viscosity of plasma, 
which ranges from 1.10 to 1.35 cP (37ºC).9 As a reference, the 
viscosity of water is 0.695 cP at 37ºC. Few studies focus on 
the rheology of blood in anemia and no precise way exists 
to establish the asymptotic value of plasma viscosity at zero 
Hct because plasma proteins are not restricted to the vas-
cular compartment. The variability of plasma viscosity is 
small and we assumed that plasma viscosity is the average 
of the reported range or 1.22 cP.10
Data on the relationship between µ and Hct for men and 
women in the normal population are reported by Kameneva 
et al,11 as shown in Figure 1, which includes data of stud-
ies reporting measurements in anemic patients. In most 
instances, the cause of anemia was not discussed. Data for 
anemic patients were reported by Stein and Sabah12 obtained 
from patients primarily afflicted with chronic renal failure 
because of malignant neoplasm. We also included data 
reported by Vázquez et al13 for healthy individuals with 
Hct lower than 35%. Stone et al14 reported data on human 
µ diluted with plasma. Cokelet15 reported theoretical values 
derived from the rigorous application of the Quemada equa-
tion for blood viscosity as a function of shear rate and Hct.16 
These data were fitted by equation (1) as follows:
µ . . . ;
.
= + × × + × ×
=




0 00 0 0 00 0 0
0
 (1)
Figure 1. Blood viscosity as a function of hematocrit of normal and 
anemic individuals. Plasma viscosity 1.22 cP is the average of the 
available data in the literature.
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The Effect of Transfusion on Hct, Blood 
Viscosity, and DO2
The increase in volume owing to RBC transfusion on Hct is 
the result of changes of plasma volume caused by changes of 
capillary pressure, which induce fluid filtration or absorption 
according to the Starling-Landis mechanism of fluid balance.17
The trajectory of fluid overload induced by transfusion is 
not well established. We assumed that blood volume returns 
to normovolemia after an unknown period after transfusion.
To evaluate how transfusion changes Hct, we assumed 
a stoichiometric effect and calculated the resulting Hct as 
the ratio of total RBC volume resulting from the transfusion 
and the total circulating volume resulting from transfusion. 
In our model, a unit of PRBCs has a volume of 300 mL and 
65% Hct thus transfusing n units of PRBCs changes Hct 
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where Hct is that of the anemic patient and bv is the 
patient’s initial blood volume, or 5 L.
The rate of DO2 is thus determined by the product:
DO CO CaO or Hct2 2= × ( ) ,  (3)
where CO is determined by the pressure imparted to blood 

















Combining equations (3) and (4) for the “rigid linear 
hydraulic system” at constant pressure, CO becomes a func-
tion of blood viscosity and a constant k because the vessel 
radius r and length l are constant. CaO2 is therefore directly 
proportional to Hct and DO2 from equation (3) becomes:






The change in posttransfusion DO2,T relative to DO2,a in 
anemic conditions defines the ratio RT,a, which eliminates 




















Because the parameters in equation (6) are all known or 
can be measured, the ratio RT,a gives a direct measure of how 
anemia affects DO2 as Hct changes as a result of transfusion.
O2 Diffusional Exit and the Effect of Blood Flow 
Velocity on DO2
Equation (5) describes how DO2 responds to changing Hct 
assuming that blood O2 saturation does not change during 
transit from the lungs to the microcirculation to satisfy the 
tissue metabolism. However, because the vasculature is not 
a barrier to O2 diffusion, O2 will diffuse out of the vessels 
before blood arriving to the microcirculation. The specific 
vascular locale of DO2 was assumed to be the capillary sys-
tem, although Duling and Berne18 reported that terminal 
arterioles also provide a significant amount of O2 to the tis-
sue. In previous work we confirmed this observation, find-
ing that most O2 is delivered by the arteriolar system and 
that capillary blood pO2 in most mammals was in the range 
of 25 to 30 mm Hg owing to the diffusional loss.19
Data on microvascular and central pO2 are available from 
the awake window chamber hamster (a fossorial species) 
model.20 In this model, central pO2 averaged 61.9 mm Hg, 
or 88% O2 saturation. Assuming that the nutritional circula-
tion begins at the level of A3 arterioles, whose pO2 is ~41 
mm Hg, blood O2 saturation at that stage is approximately 
76%.19 Consequently, we modeled that the saturation change 
in blood from central to peripheral was 12.0%. We then 
extrapolated to estimate the O2 saturation loss between the 
lungs and the start of the nutritional microcirculation. For an 
arterial saturation of 100%, A3 O2 saturation would be:
pO A3arterioles = or 86 42 100 88 76% % % . %= =X X
and the absolute change in saturation between central blood 
(100%) and the A3 arterioles = 13.6% ~ 14%. We, therefore, 
assumed that at the beginning of the nutritional circulation, 
blood O2 content had decreased by 14% owing to diffusion 
in normal conditions.
To model O2 delivery resulting from diffusion, we used 
the following logic. Oxygen exits from the blood vessels by 
constant diffusion and is driven by the O2 concentration 
gradient between blood and tissue. Therefore, the flux of O2 
arriving to the nutritional microcirculation is the difference 
between DO2 and the flux of O2 that exits the blood vessels 
by diffusion (FO2,diff). The increase of viscosity lowers blood 
flow, increasing the time for diffusion to extract O2 and fur-
ther decreasing DO2 in the microcirculation.
A model for describing DO2 in anemia relative to normal 
DO2 was formulated by writing the O2 flux balance for the 
rate of O2 delivery to the microcirculation DO2,mic as:
DO DO FO2 mic 2 2 diff, ,= −  (7)
where DO2 was the product of blood flow (ie, CO, 5 L/min) 
× Hct of fully O2 saturated RBCs as per equation (3).
The flux FO2,diff is a function of the O2 concentration gra-
dient between the amount of O2 in blood and the O2 dis-
solved in the tissues. The calculation of how the diffusional 
exit of O2 varies with changes in CO was not possible. We 
thus simplified the analysis by focusing on the relative 
rather than absolute magnitude of change. In this context, 
geometry for the rigid linear hydraulic system model is con-
stant for all conditions, and the principal variables are DO2, 
the longitudinal vascular O2 concentration gradient result-
ing from O2 exit, and the transmural O2 gradient, ie, the 
local difference between intravascular and tissue O2 concen-
tration. Several potential solutions address this problem but 
none deals with Hct changes simultaneously affecting µ and 
DO2. Furthermore, this problem is usually solved for single 
cylindrical tubes, not networks.
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A simplified problem is formulated by assuming that the 
gradient that causes O2 exit, determined by intravascular 
Hct and the tissue O2, is characterized by a single nomi-
nal value. This assumption is largely justified because the 
changes in O2 transport resulting from transfusion of 1 to 
3 units of blood are relatively small. Neglecting this effect 
permitted us to model that the diffusional O2 exit is primar-
ily determined by the residence time of blood in the pre-
microcirculation blood vessel, which is inversely related to 
blood flow velocity and therefore directly related to µ.
The dependence of the diffusional loss on the content 
of O2 of blood is less pronounced than the dependence 
on viscosity, because tissue pO2 tends to track blood pO2. 
Therefore, we assume that O2 delivery to the microcircula-
tion DO2,mic (a,N) was determined by changes resulting from 
effects on blood flow minus the diffusional loss determined 
by blood flow velocity (which is dependent on viscosity) 
according to the following equation:
DO DO 45 14 DO 452 mic a N 2 2
a N
, ( , ) ,% . %
/ ,





where Ra,N is the ratio of DO2 between anemic (a) and nor-
mal conditions (N), and µa and µN are the blood viscosities in 
the anemic and normal condition, respectively.
This expression is consistent with the physiological rela-
tionship that higher µ, resulting from increased Hct, leads 
to a higher intravascular O2 concentration, an increased rate 
of diffusional oxygen loss, and eventually decreased DO2 at 
the capillary bed. Setting DO2 (45%) = 1 and transposing, we 
obtained the DO2 in anemia relative to normal:
Rel DO 142 mic a N a, ( , ) , . / .= − ×Ra N N0 µ µ  (9)
In the anemia transfusion scenario, characteristics of the 
normal state are not known, and therefore this analysis is 
difficult to make. However, it is also informative to obtain 
a relative measure of the resulting intervention, namely the 
change in O2 delivery DO2,mic relative to the anemic condi-
tion resulting from transfusing n units, which can be esti-
mated by using the ratio RT,a defined in equation (6), which 
describes the change in DO2 induced by blood transfusion 
(BT) in an anemic individual given by:
Rel DO 142 mic T a, ( , ) , . .= − ×RT a T a0 µ µ  (10)
Physiology and Physics of the O2 Diffusional 
Loss
Our model includes an “O2 diffusion loss,” which identi-
fies a fraction of DO2 that does not contribute to supplying 
O2 to the tissue because it is consumed by the vessel walls 
and is shunted to venules running in parallel. Data on this 
phenomenon are available from pO2 measurements in an 
awake hamster model with sufficient resolution to discern 
how pO2 varies as blood transits from large to small arteri-
oles, through the capillaries, and then from small venules to 
large.19 These data exist only for “window chamber” ham-
sters and show that capillaries have the lowest pO2 in the 
vascular network. The data are derived from measurements 
with a spatial resolution of ±2 µm in subcutaneous muscle, 
adipose, and connective tissue. There are comparable data 
for the hamster cheek pouch, but this tissue is not in a win-
dow chamber and has to be irrigated. As a consequence the 
lowest pO2 is that of the irrigation solution, which tends to 
be contaminated by atmospheric pO2.21
Overall “diffusional loss” thus comprises both O2 shunt-
ing to the venular circulation and the local O2 consumption 
in the vascular and microvascular vessel wall, which is a 
true O2 “loss” occurring before O2 enters the tissue in all 
blood vessels.21,22
A fraction of the diffusional O2 “loss” thus does not par-
ticipate in tissue metabolism, but is shunted back into the 
venules, because of the parallel and juxtaposed configura-
tion of arterioles and venules, which shunt O2 to the venous 
return.23
The underlying mechanics of this “loss” and/or “shunt-
ing” is that oxygenated blood moves in pipes whose walls 
are as permeable to O2 exit as the plasma in which O2 dif-
fuses. As a consequence, vessel walls offer little resistance 
to O2 exit and the quantity of O2 that arrives to the micro-
circulation is the difference between the rate at which O2-
carrying blood arrives to the microcirculation and the rate at 
which O2 exists in the premicrocirculatory vessels. A model 
of this process is transporting water in a leaky container. 
The quantity of water arriving at the destination is a func-
tion of the difference between the container velocity and the 
rate of the water leak.
RESULTS
Our principal results are shown in Figure 2, which describes 
the effect of transfusing n units of blood in conditions of 
normovolemic anemia ranging from an Hb deficit of 0% to 
80% (or Hct). We found that transfusion of up to 3 units of 
blood had practically no effect on DO2 unless Hb is less than 
approximately a 60% Hb deficit or 5.8 g/dL. Improvements 
in DO2 ranged from 14% for transfusion of 0.5 units to 47% 
after transfusions of 3 units relative to DO2 in the anemic 
condition. Equation (10) assumes that the resulting Hct is 
determined by the changes in RBC concentration and blood 
volume associated with each given number of units trans-
fused and implies that the blood volume will be permanently 
increased (Figure 2A). This assumption is unlikely consid-
ering that transfusion of 2 units expands blood volume by 
12% according to our model. Although the posttransfusion 
change of blood volume with time is not specifically known, 
normalization of blood volume will lead to further increases 
of Hct. The effect of such normalization of blood volume is 
shown in Figure 2B.
Figure  3 confirms that when blood volume normalizes 
after transfusion, transfusing 0.5 to 3.0 units of PRBCs will 
cause DO2 to decrease for all Hb concentrations greater than 
5.8 g/dL, an effect that reverses abruptly for anemic condi-
tions with lower Hb levels.
DISCUSSION
In our mathematical simulation of the effects of transfu-
sion on DO2, we found that transfusion does not increase 
DO2 unless the deficit in Hct (or Hb) is greater than 60% of 
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a normal baseline (blood Hb <5.8 g/dL) regardless of the 
number of units transfused. This surprising lack of increase 
in DO2 is the result of transfusion-associated increases in 
blood viscosity, which not only lowers blood flow to capil-
lary beds, but also increases the diffusional O2 loss before 
blood arriving at the nutritional circulation.
The “diffusional O2 loss” refers specifically to O2 that is 
not delivered by the microcirculation. Oxygen exiting blood 
vessels should be consumed in the tissue, thus contributing 
to nutritional DO2. However, the configuration of arterioles 
and venules, running in parallel,24 indicates that this O2 
does not contribute to the tissue metabolic demand, because 
it returns via the venous circulation as a result of premicro-
circulatory arteriovenous O2 shunting, whose magnitude is 
inversely related to blood flow velocity. As a consequence, 
lowering blood flow velocity increases the O2 shunting. In 
our model, the diffusional loss is 14% of DO2 in the normal 
circulation, which decreases to approximately 7% of DO2 in 
the 50% anemia as shown in Figure 4.
We reiterate that the effects shown by our model only 
deal with the physical aspects of the problem and ignore the 
effects that transfusion per se may have on the circulation as 
a whole or on cardiac function. However, because changes 
in µ are likely relatively large, other effects of transfusion 
that increase O2 delivery would need to be as large to have 
an impact.
Our model assumes an arterially rigid linear hydraulic 
system, where MAP is constant and TPR only changes in 
response to changes of Hct. A critical question is whether 
this assumption is applicable to the mammalian circulation. 
We are not aware of clinical data on how BT, ie, increasing 
Hct in an anemic patient, affects MAP, CO, and blood vis-
cosity. Messmer et al25 studied extensively the reverse effect 
resulting from hemodilution reporting experimental find-
ings in dogs. Comparison between human responses and 
experimental conditions is difficult and additionally com-
plicated by an experimental model. We modeled an increas-
ing Hct in our study, whereas Messmer et al focused on 
decreasing Hct.
Another critical point is to assess the evidence support-
ing the effect of changing blood viscosity on TPR in the 
absence of other effects. The data of Messmer et al allow 
testing of our model, because TPR was reported for differ-
ent levels of hemodilution and blood viscosity and at each 
Figure 2. A, DO2 after transfusion relative to anemic condition. 
Calculations at the shown Hcts show the initial DO2 after transfu-
sion relative to DO2 before transfusion for different levels of anemia 
expressed by Hb deficit. B, Change of DO2 after transfusion, when 
hypervolemia induced by transfusion subsides and blood volume 
returns to baseline. This result differs from that in Figure 2 because 
Hct is higher, because return to normovolemia requires a decrease 
in plasma volume. DO2 indicates oxygen delivery; Hb, hemoglobin; 
Hct, hematocrit.
Figure 3. Effect of transfusing n units on DO2 for different levels of 
Hb deficit after volume normalization. Transfusion of any number of 
units lowers oxygen delivery to the microcirculation when treating up 
to 60% Hb losses. Calculations were made using data from Figure 
2. DO2 indicates oxygen delivery; Hb, hemoglobin.
Figure 4. Effect of Hct on diffusional oxygen exit. ○: % O2 diffu-
sional exit at each level of anemia relative to DO2 at Hct 45%. As 
an example, diffusional exit of DO2 is 14% at a Hct of 45% com-
pared with 7.1% at Hct of 22.5%. DO2 indicates oxygen delivery; 
Hct, hematocrit.
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level of Hct in a manner similar to our Figure  5. Thus, if 
we assume that increasing and decreasing Hct are equiva-
lent, we find that increasing Hct in the circulation of dogs 
behaves as our model, because MAP is approximately con-
stant (122 ± 4 mm Hg over the Hct range of 7.8%–40.0%), 
and changes in CO are exclusively the result of changes of µ.
The experimental study of Messmer et al was based on 
normovolemic anesthetized dogs, identical to our model. 
Anesthesia in general lowers CO as well as macro- and 
microcirculatory regulation26; therefore, comparison of 
these 2 models is more realistic than comparing either 
model with the nonanesthetized condition, because Ickx et 
al27 show that hemodilution and anesthesia decrease CO by 
comparison to hemodilution in the awake state indicating 
the presence of additional controls beyond merely physical 
reactions of the inert vasculature.
The effects on DO2 resulting from normalization of blood 
volume after transfusion are also significant. Transfusion 
increases blood volume even if it were possible to transfuse 
only RBCs. The additional volume administered with PRBCs 
can expand blood volume by 10% and greater for transfusions 
greater than 2.0 units. The time course governing the eventual 
excretion of this additional volume is not specifically known, 
but it is unlikely to be permanent. On normalization of the 
initial volume to that before transfusion, the Hct will increases 
even more, which in our model further worsens DO2.
Our model is specific to treating normovolemic ane-
mia in nonbleeding conditions. To understand the effect 
of transfusion in anemic hypovolemia, we computed the 
effects of transfusing a 50% anemic patient (Hct 22.5%) and 
an 80% anemic patient (Hct 9%) in patients with a 20% intra-
vascular volume deficit (4-L blood volume). In the first case, 
transfusion of 1 unit of PRBCs caused Hct to increase from 
22.5% to 25.5% for hypovolemia (instead of 24.9% for nor-
movolemia), changing posttransfusion viscosity from 2.68 
cP to 2.74 cP and decreasing DO2 by approximately 1%. In 
the second case, transfusing 3 units in extreme anemia (Hct 
9%) increased DO2 by 2.5% over that in the normovolemic 
patient. Thus, the limited effect of transfusing hypovolemic 
patients is the result of the same phenomenon that limits 
the effectiveness of blood transfusion in general, namely the 
effects of increased Hct and blood viscosity.
Our results show that transfusions of up to 3 units to cor-
rect for up to a 55% Hb deficit causes DO2 to decrease rela-
tive to the anemic state (Figure 2A) and that the fall in DO2 
worsens as blood volume normalizes (Figures  2B and 3). 
Increases in DO2 relative to anemia only occur in our model 
when treating Hb deficits greater than 60%. However, the 
actual improvement obtained is generally surprisingly 
small. A 3-unit transfusion in a patient with 80% Hct deficit 
(Hb = 2.9 g/dL) causes DO2 to change from 0.22% to 0.33% 
of normal.
One unknown factor is that the organism could eventu-
ally adapt to the increased blood viscosity and establish a 
new operating set point for normalized Hct and CO because 
of the significant increase of blood viscosity. Incorporating 
that factor may have changed our findings.
Considering the assumptions made, and the many fac-
tors that could influence DO2, including the variability 
between individuals and quantity of RBCs administered 
per transfusion, it is possible that in the real world, transfu-
sion may increase DO2. However, our simulation suggests 
that the change in DO2 will be small relative to the anemia 
being treated and well within the variability of many factors 
that control and measure DO2. We thus raise the question 
that transfusion may have limited benefit considering the 
available evidence on adverse effects of transfusion.28
A limitation of our model is that we do not include other 
factors that adapt the circulation to anemia and mitigate the 
decrease of O2 availability to the prenutritional circulatory 
compartment. In particular, a left shift of the O2–Hb disso-
ciation curve would decrease the percentage of diffusional 
O2 exit that we assume to be 14% in our model, thus increas-
ing O2 availability in anemia and DO2. An often mentioned 
factor is the increased O2 extraction that may occur during 
anemia resulting from increased capillary density; however, 
studies in the microcirculation in extreme hemodilution 
tend to show a decrease in functional capillary density.20 A 
weakness of our model is the assumption that MAP does 
not change as a function of transfusion, ie, changes in CaO2, 
although the experimental study of Messmer et al supports 
this assumption for anesthetized, isovolemic, and anemic 
dogs. Furthermore, we assume that blood is a Newtonian 
fluid, which is mostly valid for Hct deficits of 40% or greater.4
Another critique is the simplistic treatment of the com-
plex physics associated with the change of CaO2 resulting 
from changes in Hct. We previously reported the effect of 
flow velocity on DO2 for a single tube29 and the effect of 
blood viscosity on O2 delivery in a branching network.30 In 
this study, we developed a hybrid approach for the solu-
tion of how DO2 is managed in anemia on transfusion of 
PRBCs by establishing a mass balance between O2 convec-
tive supply and diffusional delivery referred to specifi-
cally in in vivo mammalian microvascular data. Clearly a 
more sophisticated approach based on exact solutions for 
Figure 5. Comparison of CO as a function of Hct in the current 
model (circles) and results of Messmer et al24 (squares) on changes 
induced by hemodilution in dogs and using measured dog viscosity 
data in the model. This comparison simulates increasing Hct and 
CO from an anemic condition resulting from 10% Hct. Model data 
are fitted by a quadratic relationship, whereas the experimental vari-
ability inherent to the measurement of CO and blood viscosity is 
best fitted by a linear relationship. CO indicates cardiac output; Hct, 
hematocrit.
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branching circulatory systems characteristics of the differ-
ent organs would make the analysis more accurate.31
In summary, we found in a mathematical model of the 
human circulation that for the majority of anemic and nor-
movolemic conditions encountered clinically, increases in 
DO2 were modest at best or nonexistent. One limitation of 
this model is the assumption that cardiac function is inde-
pendent of Hct. This critique is valid, because cardiac func-
tion is determined by DO2. However, the experiments of 
Messmer et al show the existence of conditions where car-
diac function is only a function of blood viscosity.
Our model suggests that transfusion of 1 to 2 units of 
PRBCs is unlikely to increase DO2 unless treating extreme 
normovolemic anemia where Hb <5.8 g/dL (Hct deficit 
>60%). Because this finding is not consistent with clinical 
practice, we hypothesize the existence of mechanisms not 
addressed in our model that ultimately negate the effect of 
increasing viscosity on blood flow and facilitate DO2. One 
possibility is the decrease of TPR through vasodilatation, 
which may be mediated by increased mechanotransduction 
and production of nitric oxide.32–34 However, in these studies, 
changes in Hct were induced without changes in volume.
The presence of additional phenomena not related to the 
physical effects described in our modeling is also suggested 
by Yuruk et al35 who investigated the sublingual microcircu-
lation in patients receiving up to 3 units of blood on under-
going cardiopulmonary bypass-assisted heart surgery and 
in anemic patients.36 Both of these studies treated Hb defi-
cits of 55% and found increased functional capillary density, 
microvascular Hct, and tissue pO2, although no evidence of 
increased microvascular perfusion. In contrast, a previous 
study by Creteur et al37 did not find any change in tissue pO2.
CONCLUSIONS
Using a physical model of transfusion, we found that 
increasing Hct in anemic patients increases blood viscosity, 
which severely limits the effect of increasing Hct on DO2. In 
our model, transfusing up to 3 units of PRBCs to treat 5.8 g 
Hb/dL does not increase DO2 and may reduce DO2 when 
correcting a higher Hb level. We also show that the reduc-
tion of blood volume posttransfusion further increases Hct 
and lowers DO2.
Our analysis suggests that physical effects that underlay 
BT may preclude the possibility of transfusion increasing 
DO2 unless other effects not related to baseline hydraulic/
viscosity considerations are present. Because DO2 is the 
product of CO and Hb and because increases in Hb are lim-
ited by the number of RBC units than can be transfused, the 
effectiveness of blood transfusion thus depends primarily 
on the increases of CO. We advance the possibility that posi-
tive effects owing to transfusion may be the result of vaso-
dilation in response to increased blood viscosity. More work 
is needed to better understand how the circulation and DO2 
respond to transfusion. E
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